<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="If you purchased Tilray, Inc. (TLRY) securities between January 15, 2019 and March 2, 2020, you have until May 5, 2020, to ask the court to be appointed lead plaintiff for the class. If you suffered a loss as a result of Tilray’ misconduct, click here.” data-reactid=”20″>If you purchased Tilray, Inc. (TLRY) securities between January 15, 2019 and March 2, 2020, you have until May 5, 2020, to ask the court to be appointed lead plaintiff for the class. If you suffered a loss as a result of Tilray’ misconduct, click here.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Tilray, Inc. (TLRY) Accused of Misleading Shareholders ” data-reactid=”21″>Tilray, Inc. (TLRY) Accused of Misleading Shareholders
According to the complaint, on January 15, 2019, Tilray announced its entry into a marketing and revenue sharing agreement with Authentic Brands Group (“ABG”), touting that “through this agreement, Tilray and ABG [will] join forces at the intersection of science and brand to connect consumers with innovative health and wellness products.” Tilray maintained these positive statements throughout the relevant period, assuring investors that the alliance “will complement or augment [its] existing business.” Despite auspicious projections for the agreement, on March 2, 2020, Tilray released its financial results for the fourth quarter and full year 2019, reporting a net loss for the year of $321.2 million and disclosing that “the Company recorded non-cash charges of $112.1 million related to impairment of the Authentic Brands Group LLC (‘ABG’) agreement as well as $68.6 million in inventory reserves.” Since this news, Tilray’s stock price has precipitously fallen 48% from its closing price of $15.35 per share on March, 2, 2020, currently trading at around $8 per share.
Contact us to learn more:
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Leo Kandinov
(800) 350-6003
[email protected]
Shareholder Information Form” data-reactid=”24″>Leo Kandinov
(800) 350-6003
[email protected]
Shareholder Information Form
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Robbins LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. Click here to receive free alerts from Stock Watch when companies engage in wrongdoing.” data-reactid=”25″>Robbins LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. Click here to receive free alerts from Stock Watch when companies engage in wrongdoing.
Attorney Advertising. Past results do not guarantee a similar outcome.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="View source version on businesswire.com: https://www.businesswire.com/news/home/20200504005741/en/” data-reactid=”27″>View source version on businesswire.com: https://www.businesswire.com/news/home/20200504005741/en/
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Contacts” data-reactid=”28″>Contacts
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
[email protected]
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com” data-reactid=”29″>Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
[email protected]
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com
Add Comment